Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Peter Turcsanyi"'
Autor:
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, Jakub Savara, Eliska Ochodkova, Yvona Brychtova, Jan Molinsky, Martin Simkovic, David Starostka, Jan Novak, Ondrej Janca, Martin Dihel, Pavlina Ryznerova, Lekaa Mohammad, Tomas Papajik, Eva Kriegova
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract The tissue microenvironment in chronic lymphocytic leukaemia (CLL) plays a key role in the pathogenesis of CLL, but the complex blood microenvironment in CLL has not yet been fully characterised. Therefore, immunophenotyping of circulating i
Externí odkaz:
https://doaj.org/article/def86669326e46929974b57867c48612
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Inhibitors of B-cell receptor signaling, ibrutinib and idelalisib, and BCL-2 antagonist, venetoclax, have become the mainstay of treatment for chronic lymphocytic leukemia (CLL). Despite significant efficacy in most CLL patients, some patients develo
Externí odkaz:
https://doaj.org/article/7e4b32f8464f406cb9c64c48297cb66a
Autor:
Gayane Manukyan, Tomas Papajik, Zuzana Mikulkova, Renata Urbanova, Veronika Smotkova Kraiczova, Jakub Savara, Milos Kudelka, Peter Turcsanyi, Eva Kriegova
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Despite the shared pattern of surface antigens, neoplastic cells in chronic lymphocytic leukemia (CLL) are highly heterogeneous in CD5 expression, a marker linked to a proliferative pool of neoplastic cells. To further characterize CD5high and CD5low
Externí odkaz:
https://doaj.org/article/37eb7bf4416c48a69a1de4a8a140e415
Autor:
Adam Kuba, Tomas Szotkowski, Peter Rohon, Edgar Faber, Peter Turcsanyi, Jaromir Hubacek, Milena Holzerova, Vojtech Prasil, Marie Jarosova, Karel Indrak
Publikováno v:
Biomedical Papers, Vol 159, Iss 2, Pp 294-298 (2015)
Background: Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia with high curability rates. However, it is often accompanied by severe coagulopathy and bleeding risk and thus represents a potentially fatal haematological emerg
Externí odkaz:
https://doaj.org/article/ea6b0196dc764f169dc3667274f75947
Publikováno v:
British Journal of Haematology. 199:371-381
Germline pathogenic ATM (ataxia-telangiectasia mutated) variants are associated with the risk of multiple cancers; however, genetic testing reveals a large number of ATM variants of uncertain significance (VUS). Here, we studied germline ATM variants
Autor:
Peter Turcsanyi, Anna Sedláková
Publikováno v:
Selected Scientific Papers: Journal of Civil Engineering, Vol 14, Iss 2, Pp 51-60 (2019)
Phenomenon of today′s era is lowering overall energy performance and greenhouse gas emissions. European Union and its members came from an “uncontrollable” fossil fuel usage to an era of dependence reduction from fossil fuel usage. EU industry
Autor:
Gayane Manukyan, Zuzana Mikulková, Jakub Savara, Zuzana Kubová, Peter Turcsanyi, Markéta Trajerová, Eva Kriegova, Tomas Papajik
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 4922, p 4922 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 4922, p 4922 (2021)
Simple Summary Chronic lymphocytic leukaemia (CLL) is a heterogeneous chronic disease characterised by the clonal expansion of mature CD19+CD23+CD5+ B-cells in blood, bone marrow and lymphoid tissue. Despite the CLL tumour cell population showing con
Publikováno v:
65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Publikováno v:
Applied Mechanics and Materials. 887:393-400
The goal of this paper is to assess two ultra-low-energy family houses from thermo-physical aspects and environmental perspectives. Thermo – physical evaluation, done in two-dimensional PC software Area, has shown results that consent with the newe
Autor:
Milos Kudelka, Jan Molinsky, Gayane Manukyan, Renata Urbanova, Martin Simkovic, Eliska Ochodkova, Peter Turcsanyi, Pavlina Ryznerova, Ondrej Janca, Jan Novák, Eva Kriegova, Zuzana Mikulková, David Starostka, Tomas Papajik, Yvona Brychtová, Lekaa Mohammad, Martin Dihel, Jakub Savara
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Background: The tissue microenvironment in chronic lymphocytic leukemia (CLL) plays a key role in promoting neoplastic cell survival, proliferation, and drug resistance. There is a lack of complex characterization of CLL blood microenvironment and it